- call +1-201-465-4211
- email sales@mrinsights.biz
Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
Scope of the Report:
This report focuses on the Ophthalmic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.
According to the American Academy of Ophthalmology over 27.1 million of North American population is suffering from Primary Open Angle Glaucoma (POAG) and this number is constantly rising. Thus, increasing eye disorders is fueling the growth of the global ophthalmic drugs market.
It was reported that around two-third of the population in the Asia Pacific region are blind or vision impaired. Moreover, development of various novel technologies in developing markets such as China & India is expected to improve healthcare facilities.
The worldwide market for Ophthalmic Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Santen Pharmaceutical
Valeant Pharmaceuticals
Shire
Novartis
Genentech
Allergan
Sun Pharmaceutical Industries
Actavis Generics
Regeneron Pharmaceuticals
Pfizer
Johnson and Johnson
Bausch and Lomb
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Market Segment by Applications, can be divided into
Hospital
Clinic
Pharmacy
There are 15 Chapters to deeply display the global Ophthalmic Drugs market.
Chapter 1, to describe Ophthalmic Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Ophthalmic Drugs, with sales, revenue, and price of Ophthalmic Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Ophthalmic Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Ophthalmic Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Ophthalmic Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Ophthalmic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Anti-allergy
1.2.2 Anti-VEGF Agents
1.2.3 Anti-inflammatory
1.2.4 Anti-glaucoma
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Pharmacy
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Santen Pharmaceutical
2.1.1 Business Overview
2.1.2 Ophthalmic Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Santen Pharmaceutical Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Valeant Pharmaceuticals
2.2.1 Business Overview
2.2.2 Ophthalmic Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Valeant Pharmaceuticals Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Shire
2.3.1 Business Overview
2.3.2 Ophthalmic Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Shire Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Ophthalmic Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Genentech
2.5.1 Business Overview
2.5.2 Ophthalmic Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Genentech Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Allergan
2.6.1 Business Overview
2.6.2 Ophthalmic Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Allergan Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sun Pharmaceutical Industries
2.7.1 Business Overview
2.7.2 Ophthalmic Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sun Pharmaceutical Industries Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Actavis Generics
2.8.1 Business Overview
2.8.2 Ophthalmic Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Actavis Generics Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Regeneron Pharmaceuticals
2.9.1 Business Overview
2.9.2 Ophthalmic Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Regeneron Pharmaceuticals Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Pfizer
2.10.1 Business Overview
2.10.2 Ophthalmic Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfizer Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Johnson and Johnson
2.11.1 Business Overview
2.11.2 Ophthalmic Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Johnson and Johnson Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Bausch and Lomb
2.12.1 Business Overview
2.12.2 Ophthalmic Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Bausch and Lomb Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Ophthalmic Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Ophthalmic Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Ophthalmic Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Ophthalmic Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Ophthalmic Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Ophthalmic Drugs Market Analysis by Regions
4.1 Global Ophthalmic Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Ophthalmic Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Ophthalmic Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Ophthalmic Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Ophthalmic Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Ophthalmic Drugs Sales and Growth Rate (2013-2018)
4.5 South America Ophthalmic Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Ophthalmic Drugs Sales and Growth Rate (2013-2018)
5 North America Ophthalmic Drugs by Countries
5.1 North America Ophthalmic Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Ophthalmic Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Ophthalmic Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Ophthalmic Drugs Sales and Growth Rate (2013-2018)
6 Europe Ophthalmic Drugs by Countries
6.1 Europe Ophthalmic Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Ophthalmic Drugs Sales and Growth Rate (2013-2018)
6.3 UK Ophthalmic Drugs Sales and Growth Rate (2013-2018)
6.4 France Ophthalmic Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Ophthalmic Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Ophthalmic Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Ophthalmic Drugs by Countries
7.1 Asia-Pacific Ophthalmic Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Ophthalmic Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Ophthalmic Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Ophthalmic Drugs Sales and Growth Rate (2013-2018)
7.5 India Ophthalmic Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Ophthalmic Drugs Sales and Growth Rate (2013-2018)
8 South America Ophthalmic Drugs by Countries
8.1 South America Ophthalmic Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Ophthalmic Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Ophthalmic Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Ophthalmic Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Ophthalmic Drugs by Countries
9.1 Middle East and Africa Ophthalmic Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Ophthalmic Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Ophthalmic Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Ophthalmic Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Ophthalmic Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Ophthalmic Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Ophthalmic Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Ophthalmic Drugs Sales and Growth Rate (2013-2018)
10 Global Ophthalmic Drugs Market Segment by Type
10.1 Global Ophthalmic Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Ophthalmic Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Ophthalmic Drugs Revenue and Market Share by Type (2013-2018)
10.2 Anti-allergy Sales Growth and Price
10.2.1 Global Anti-allergy Sales Growth (2013-2018)
10.2.2 Global Anti-allergy Price (2013-2018)
10.3 Anti-VEGF Agents Sales Growth and Price
10.3.1 Global Anti-VEGF Agents Sales Growth (2013-2018)
10.3.2 Global Anti-VEGF Agents Price (2013-2018)
10.4 Anti-inflammatory Sales Growth and Price
10.4.1 Global Anti-inflammatory Sales Growth (2013-2018)
10.4.2 Global Anti-inflammatory Price (2013-2018)
10.5 Anti-glaucoma Sales Growth and Price
10.5.1 Global Anti-glaucoma Sales Growth (2013-2018)
10.5.2 Global Anti-glaucoma Price (2013-2018)
11 Global Ophthalmic Drugs Market Segment by Application
11.1 Global Ophthalmic Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Pharmacy Sales Growth (2013-2018)
12 Ophthalmic Drugs Market Forecast (2018-2023)
12.1 Global Ophthalmic Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Ophthalmic Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Ophthalmic Drugs Market Forecast (2018-2023)
12.2.2 Europe Ophthalmic Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Ophthalmic Drugs Market Forecast (2018-2023)
12.2.4 South America Ophthalmic Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Ophthalmic Drugs Market Forecast (2018-2023)
12.3 Ophthalmic Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Ophthalmic Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Ophthalmic Drugs Market Share Forecast by Type (2018-2023)
12.4 Ophthalmic Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Ophthalmic Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Ophthalmic Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Ophthalmic Drugs Picture
Table Product Specifications of Ophthalmic Drugs
Figure Global Sales Market Share of Ophthalmic Drugs by Types in 2017
Table Op
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
